Citigroup and Bank of America have raised/restated buy ratings for Haemonetics Corporation.
3 reports, 2 independent
Updated Aug 7
Gone quiet
- Reports
- 3
- Developments
- 1
- Repetition
- 67%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Citigroup and Bank of America have raised/restated buy ratings for Haemonetics Corporation.
Who's involved
What this event is mainly aboutKeep exploring
Part of
Goldman Sachs, Citigroup, and Bank of America are involved in managing major financial offerings.Also in this story
- Institutional investors included in the buy-in, which purchased 2.2 crore shares in the exit, involving the company co-founded by Alakh Pandey.
- Goldman Sachs and Bank of America face regulatory scrutiny, including subpoenas from the SEC, regarding their financial activities.
The entities involved
-
Citigroup
American investment bank and financial services corporation
-
Bank of America
American multinational banking and financial services corporation
Related events
- Citigroup reaffirmed buy rating on STMicroelectronics (STM), and Bank of America upgraded its rating to buy.
- Citigroup restated a buy rating on the stock of Stora Enso.
- Citigroup upgraded the stock rating for Truist Financial on June 26, 2025.
- Citigroup and Truist Financial issued buy ratings and increased price targets for Cisco.
- Citigroup reissued a buy rating on Paylocity shares.